Year: 2024
Type: review
Abstract: Cardiovascular disease (CVD) is the leading cause of death worldwide. MicroRNAs (MiRNAs) have attracted considerable attention for their roles in several cardiovascular disease states, including both the physiological and pathological processes. In this review, we will briefly describe microRNA-181 (miR-181) transcription and regulation and summarize recent findings on the roles of miR-181 family members as biomarkers or therapeutic targets in different cardiovascular-related conditions, including atherosclerosis, myocardial infarction, hypertension, and heart failure. Lessons learned from these studies may provide new theoretical foundations for CVD.
Source: The FASEB Journal
Authors: Bingjie Lv, Shaolin He, Peixin Li, Shijiu Jiang, Dazhu Li, Jibin Lin, Mark W. Feinberg
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Awards: Non-coding RNAs in ischemic myocardial disease and diabetes: discovery, pathobiology, and therapeutic intervention, miR-615, AKT/eNOS signaling, and angiogenesis, G1458866967, G2992645176, LncRNA MAARS, macrophage apoptosis, and atherosclerosis, G4039235295, Non-coding RNAs in diabetic critical limb ischemia: discovery, pathobiology, and therapeutic intervention, G5487005603, G5804366060, miR-181b, endothelial cells, and vascular inflammation, G6058642771, LncRNA SNHG12, vascular senescence, and atherosclerosis, G7689176026, G8003939408, miR-130b, angiogenesis, and diabetic critical limb ischemia
OpenAlex ID: W4396556093